Abstract 2194: Preclinical pharmacological profiling of ACP-5862, the major metabolite of the covalent BTK inhibitor acalabrutinib, displays intrinsic BTK inhibitory activity
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Allard Kaptein Tjeerd Barf |
| Publication date | July 1, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |